SCHERING PLOUGH
Company Information
Ticker Symbol: SGP Exchange: NYSE Contact Info: 2000 Galloping Hill Road Kenilworth 07033 908 298-4000 CEO/President: Fred Hassan Industry: Medical - Drugs    /    Standard Industry Code: 2834 Description: Schering-Plough Corporation and its subsidiaries are engaged in the discovery, development, manufacturing and marketing of pharmaceutical products worldwide. The company operates primarily in the prescription pharmaceutical marketplace. However, where appropriate, the company has sought regulatory approval to switch prescription products to over-the-counter status as a means of extending a product's life cycle.
Share Information
Shares Outstanding: 1,633,940 (000) Market Value: 46,403,872 ($000) Percentage of Inst. Shareholders: 69.94% Number of Inst. Shareholders: 0.66% Last Quarter Sales: 4499.00 ($Mil.) Last Quarter Net Income: 515.00 ($Mil.) Last Quarter EPS: 0.40 P/E Ratio: 16 Most Recent Earnings: 0.40 on 10/22/09 Earnings Per Share: 1.40 Most Recent Split: 2-1 on 12/03/98 Annual Dividend Rate: .26 Most Recent Dividend: 0.065 on 10/22/09 Annual Dividend Yield: .92%

Media General Financial Services expressly disclaims all warranties of fitness of all data presented on its Web sites. In no event shall Media General Financial Services have any liability of any kind for any damages even if notified of the possibility of such damages.